| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 302.862 | 0 | 40.973 | 43.998 | 48.197 | 37.650 | 48.263 | 55.776 | 55.790 | 56.970 |
| Total Income - EUR | 366.527 | 0 | 41.054 | 43.998 | 48.284 | 37.666 | 48.263 | 55.776 | 55.792 | 56.970 |
| Total Expenses - EUR | 303.997 | 42.301 | 18.821 | 22.494 | 18.977 | 18.292 | 12.311 | 14.325 | 17.536 | 15.755 |
| Gross Profit/Loss - EUR | 62.530 | -42.301 | 22.234 | 21.504 | 29.307 | 19.374 | 35.952 | 41.451 | 38.256 | 41.216 |
| Net Profit/Loss - EUR | 49.197 | -42.301 | 21.002 | 20.184 | 27.858 | 18.330 | 34.533 | 40.084 | 32.749 | 34.753 |
| Employees | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 0 |
Check the financial reports for the company - Imuno Diagnostika Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 496.159 | 484.462 | 466.478 | 458.073 | 441.924 | 426.405 | 409.967 | 404.234 | 396.026 | 386.869 |
| Current Assets | 228.882 | 143.564 | 166.302 | 152.882 | 104.294 | 114.637 | 113.531 | 76.591 | 69.900 | 58.418 |
| Inventories | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | 111.016 | 106.326 | 107.236 | 101.354 | 94.831 | 91.617 | 86.640 | 73.381 | 67.683 | 56.918 |
| Cash | 117.866 | 37.238 | 59.066 | 51.528 | 9.463 | 23.020 | 26.890 | 3.211 | 2.217 | 1.501 |
| Shareholders Funds | 725.040 | 626.694 | 626.146 | 604.004 | 537.980 | 528.539 | 515.570 | 407.378 | 438.892 | 378.784 |
| Social Capital | 56 | 100 | 99 | 97 | 95 | 93 | 91 | 91 | 91 | 90 |
| Debts | 0 | 1.332 | 6.708 | 6.952 | 8.308 | 8.807 | 7.992 | 73.513 | 27.106 | 66.576 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 3.765 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "6820 - 6820" | |||||||||
| CAEN Financial Year |
6820
|
|||||||||
Comments - Imuno Diagnostika Srl